(Q37100261)

English

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

scientific article published on March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

0 references

8

object named as

J E Sadler

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

W L Nichols

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M B Hultin

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

A H James

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M J Manco-Johnson

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

R R Montgomery

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

T L Ortel

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M E Rick

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

M Weinstein

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

B P Yawn

10

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

171-232

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Prevalence of von Willebrand disease in children: a multiethnic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Guidelines for the diagnosis and management of von Willebrand disease in Italy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hereditary pseudohaemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Interactions between von Willebrand factor and Factor VIII: where did they first meet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic induction of a releasable pool of factor VIII in human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Measurement of von Willebrand factor activity: relative effects of ABO blood type and race

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Laboratory diagnosis of congenital von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand's disease in western Europe and Israel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Von Willebrand disease type 1: a diagnosis in search of a disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A molecular approach to the classification of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Postoperative thrombocytopenia in type IIB von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

New concepts in von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic determinants of hemostasis phenotypes in Spanish families.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic heterogeneity of severe von Willebrand disease type III in the German population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand syndrome in aortic stenosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Shear stress and von Willebrand factor in health and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case–control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The Prevalence of von Willebrand disease in women with abnormal uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Frequency of inherited bleeding disorders in women with menorrhagia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Platelet functional defects in women with unexplained menorrhagia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand's disease: an important cause of dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand's syndrome: a single institution experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hepatitis viruses: genetic variants and clinical significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease: a common pediatric disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Biochemistry and genetics of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Quality control and factor VIII assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Harmonisation of factor VIII:C assay results: study within the framework of the Dutch project 'Calibration 2000'.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 3 von Willebrand disease: assessment of complications and approaches to treatment -- results of a patient and Hemophilia Treatment Center Survey in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Treatment of von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Desmopressin and type II B von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Thrombosis following desmopressin for uremic bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Cysteine-mutations in von Willebrand factor associated with increased clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Perioperative management of von Willebrand's disease in otolaryngologic surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Adenotonsillectomy in children with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of children with von Willebrand disease undergoing adenotonsillectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Otolaryngologic surgery in children with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP-induced hyponatremia in young children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hyponatremia and seizures in young children given DDAVP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP is not a panacea for children with bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Intraoperative cerebral infarction after desmopressin administration in infant with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Females with von Willebrand disease: 72 years as the silent majority

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP use during pregnancy: an analysis of its safety for mother and child

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease in the developing world

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A comparative in vitro evaluation of six von Willebrand factor concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Risks of transfusion-transmitted infections: 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemostatic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The management of von Willebrand's disease-associated gastrointestinal angiodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and bleeding in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of abnormal uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Testing for von Willebrand disease in women with menorrhagia: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical practice. Combination estrogen-progestin oral contraceptives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Female hormones and thrombosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The safety of oral contraceptives: Epidemiologic insights from the first 30 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Microwave endometrial ablation versus endometrial resection: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Five-year follow-up of endometrial ablation: endometrial coagulation versus endometrial resection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hysterectomy after endometrial ablation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Obstetric and gynaecological aspects of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

How I treat patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Maternal age and fetal loss: population based register linkage study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Maternal and fetal outcomes in pregnancies affected by von Willebrand disease type 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The duration and character of postpartum bleeding among breast-feeding women.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Secondary postpartum haemorrhage: incidence, morbidity and current management.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a reivesw of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Gene therapy. The strange case of chimeraplasty

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Bleeding manifestations in males with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of dental extractions in patients with bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2007.01643.X

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37100261&oldid=1629746414"